Geode Capital Management’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-770,483
| Closed | -$3.08M | – | 4260 |
|
|
2019
Q4 | $3.08M | Buy |
770,483
+28,205
| +4% | +$132K | ﹤0.01% | 2751 |
|
|
2019
Q3 | $3.64M | Buy |
742,278
+40,164
| +6% | +$225K | ﹤0.01% | 2578 |
|
|
2019
Q2 | $4.28M | Buy |
702,114
+48,434
| +7% | +$257K | ﹤0.01% | 2498 |
|
|
2019
Q1 | $3.8M | Buy |
653,680
+54,927
| +9% | +$567K | ﹤0.01% | 2487 |
|
|
2018
Q4 | $8.06M | Buy |
598,753
+70,528
| +13% | +$1.19M | ﹤0.01% | 1920 |
|
|
2018
Q3 | $10.3M | Buy |
528,225
+64,213
| +14% | +$1.37M | ﹤0.01% | 1898 |
|
|
2018
Q2 | $11.9M | Buy |
464,012
+63,083
| +16% | +$1.47M | ﹤0.01% | 1744 |
|
|
2018
Q1 | $8.08M | Sell |
400,929
-44,975
| -10% | -$1.05M | ﹤0.01% | 1915 |
|
|
2017
Q4 | $8.95M | Buy |
445,904
+77,983
| +21% | +$1.53M | ﹤0.01% | 1822 |
|
|
2017
Q3 | $7.62M | Sell |
367,921
-12,952
| -3% | -$219K | ﹤0.01% | 1938 |
|
|
2017
Q2 | $5.64M | Buy |
380,873
+56,679
| +17% | +$945K | ﹤0.01% | 2071 |
|
|
2017
Q1 | $5.17M | Sell |
324,194
-126,513
| -28% | -$1.82M | ﹤0.01% | 2087 |
|
|
2016
Q4 | $5.68M | Buy |
450,707
+173,460
| +63% | +$3.23M | ﹤0.01% | 1978 |
|
|
2016
Q3 | $7.76M | Buy |
277,247
+23,419
| +9% | +$786K | ﹤0.01% | 1663 |
|
|
2016
Q2 | $8.88M | Buy |
253,828
+30,817
| +14% | +$969K | ﹤0.01% | 1524 |
|
|
2016
Q1 | $6.11K | Buy |
223,011
+3,703
| +2% | +$109K | ﹤0.01% | 1744 |
|
|
2015
Q4 | $7.5M | Buy |
219,308
+13,183
| +6% | +$411K | ﹤0.01% | 1578 |
|
|
2015
Q3 | $5.92M | Buy |
206,125
+2,376
| +1% | +$102K | ﹤0.01% | 1728 |
|
|
2015
Q2 | $9.12M | Buy |
203,749
+120,932
| +146% | +$4.55M | 0.01% | 1474 |
|
|
2015
Q1 | $2.86M | Buy |
82,817
+4,474
| +6% | +$122K | ﹤0.01% | 2208 |
|
|
2014
Q4 | $2.14M | Buy |
+78,343
| New | +$1.9M | ﹤0.01% | 2382 |
|
Other funds holding DPLO
Geode Capital Management's DPLO Position: Q1 2020 in Review
Geode Capital Management sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 770,483 shares — an estimated $3.08M sold.
Geode Capital Management first reported a position in DPLO in Q4 2014 and held it in 21 quarters. The position peaked at $11.9M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Geode Capital Management reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Geode Capital Management sold 770,483 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $3.08M.
- Geode Capital Management first reported a position in DIPLOMAT PHARMACY, INC. in Q4 2014 and held it in 21 quarters.
- Geode Capital Management's DIPLOMAT PHARMACY, INC. position peaked at $11.9M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Geode Capital Management's 13F filing for Q1 2020, filed 14 May 2020.